Cortical spreading depression as a site of origin for migraine: Role of CGRP

Cephalalgia. 2019 Mar;39(3):428-434. doi: 10.1177/0333102418774299. Epub 2018 Apr 25.

Abstract

Premise: Migraine is a complex neurologic disorder that leads to significant disability, yet remains poorly understood.

Problem: One potential triggering mechanism in migraine with aura is cortical spreading depression, which can activate the trigeminal nociceptive system both peripherally and centrally in animal models. A primary neuropeptide of the trigeminal system is calcitonin gene-related peptide, which is a potent vasodilatory peptide and is currently a major therapeutic target for migraine treatment. Despite the importance of both cortical spreading depression and calcitonin gene-related peptide in migraine, the relationship between these two players has been relatively unexplored. However, recent data suggest several potential vascular and neural connections between calcitonin gene-related peptide and cortical spreading depression.

Conclusion: This review will outline calcitonin gene-related peptide-cortical spreading depression connections and propose a model in which cortical spreading depression and calcitonin gene-related peptide act at the intersection of the vasculature and cortical neurons, and thus contribute to migraine pathophysiology.

Keywords: Neurovasculature; cortical spreading depression; trigeminal nerve; vasodilation.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcitonin Gene-Related Peptide / antagonists & inhibitors
  • Calcitonin Gene-Related Peptide / metabolism*
  • Calcitonin Gene-Related Peptide Receptor Antagonists / pharmacology
  • Calcitonin Gene-Related Peptide Receptor Antagonists / therapeutic use
  • Cortical Spreading Depression / drug effects
  • Cortical Spreading Depression / physiology*
  • Humans
  • Migraine Disorders / drug therapy
  • Migraine Disorders / metabolism*
  • Receptors, Calcitonin Gene-Related Peptide / metabolism
  • Trigeminal Nerve / drug effects
  • Trigeminal Nerve / metabolism
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • Receptors, Calcitonin Gene-Related Peptide
  • Calcitonin Gene-Related Peptide